Current stock page

Financial Data

PEN Financial Data

Revenue · Earnings · Margins · Balance Sheet · Cash Flow

HealthcareMedical - DevicesScore data as of Nov 18, 2026

PENPenumbra, Inc.

Healthcare / Medical - Devices

Leader

Strong Relative Position

BullishEdge 8/10
$320.60+$1.49 (+0.47%)

Latest quote

  • Momentum
    56
  • Value
    48
  • Quality
    78
  • Risk resilience
    92
  • Sentiment
    —
algovestiq.comScore data as of Nov 18, 2026

Latest Quarter at a Glance

Quarter ended Sep 30, 2026, compared with the same quarter a year earlier.

Revenue
$410.15M
+15.6% YoY
Net income
$42.28M
−7.8% YoY
Free cash flow
$26.4M
−37.2% YoY
Operating margin
12.4%
−1.4 pts YoY

Quarterly Financial Statements

Updated Nov 19, 2026.

PEN, last 8 quarters. YoY compares the latest quarter with the same quarter a year earlier.

Income statement
Income statement, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Revenue+15.6%$410M$390M$375M$385M$355M$339M$324M$316M
Gross profit+16.6%$280M$265M$253M$262M$240M$224M$216M$211M
Operating income+3.9%$51M$41M$38M$59M$49M$41M$40M$43M
Net income−7.8%$42M$35M$33M$47M$46M$45M$39M$34M
EPS (diluted)−8.5%$1.07$0.88$0.82$1.20$1.17$1.15$1.00$0.86
Gross margin+0.6 pts68.3%67.9%67.6%68.0%67.8%66.0%66.6%66.8%
Operating margin−1.4 pts12.4%10.5%10.2%15.4%13.8%12.0%12.4%13.6%
Net margin−2.6 pts10.3%8.9%8.7%12.3%12.9%13.3%12.1%10.7%
Cash flow
Cash flow, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Operating cash flow−28.8%$42M$46M$87M$86M$58M$45M$49M$51M
Capital expenditure+7.0%−$15M−$14M−$14M−$18M−$16M−$16M−$13M−$5M
Free cash flow−37.2%$26M$33M$73M$68M$42M$29M$36M$46M
Free cash flow margin−5.4 pts6.4%8.3%19.6%17.7%11.8%8.7%11.0%14.5%
Balance sheet
Balance sheet, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
Total assets+16.1%$2.03B$1.97B$1.90B$1.83B$1.74B$1.67B$1.59B$1.53B
Total liabilities+14.5%$442M$444M$425M$399M$386M$381M$380M$382M
Shareholders' equity+16.5%$1.58B$1.53B$1.47B$1.43B$1.36B$1.29B$1.21B$1.15B
Total debt−3.5%$209M$213M$216M$220M$217M$221M$221M$223M
Cash and equivalents−20.8%$254M$205M$241M$187M$321M$422M$376M$324M
Valuation and ratios
Valuation and ratios, last 8 quarters, newest first
MetricTrendYoYSep '26Jun '26Mar '26Dec '25Sep '25Jun '25Mar '25Dec '24
P/E ratio+27.2081.2478.8174.9575.0854.0460.36258.51759.86
P/B ratio+1.538.068.278.709.356.526.899.009.25
Return on equity−2.2 pts9.9%10.5%11.6%12.4%12.1%11.4%3.5%1.2%
Debt to equity−0.030.130.140.150.150.160.170.180.19
Free cash flow yield−0.2 pts1.6%1.7%1.7%1.3%1.7%1.8%1.4%1.4%

Current Stock Metrics

Current fundamental, technical, and risk readings in one place.

Fundamental metrics
MetricValue
P/E ratio79.98x
P/B ratio7.94x
Revenue growth (YoY)15.64%
EPS growth (YoY)-8.55%
Gross margin67.98%
Operating margin12.13%
ROE10.44%
ROIC7.91%
Debt to equity0.13
FCF yield1.59%

As of Nov 18, 2026

Technical indicators
MetricValue
Close
As of Nov 18, 2026
$320.60
Volume
As of Nov 13, 2026
237,596
RSI (14)
As of Nov 13, 2026
49.51
MACD
As of Nov 13, 2026
0.09
MACD signal
As of Nov 13, 2026
0.23
MACD histogram
As of Nov 13, 2026
-0.14
ADX (14)
As of Nov 13, 2026
16.97
SMA (50)
As of Nov 13, 2026
$320.15
SMA (200)
As of Nov 13, 2026
$325.71
ATR (14)
As of Nov 13, 2026
$2.55
Historical volatility (annualized)
As of Nov 13, 2026
10.94%
Volume (20-day average)
As of Nov 13, 2026
394,611
Risk measures
MetricValue
Resilience score92/100
Beta0.19
Annual volatility19.46%
Max drawdown-12.23%
Sharpe ratio0.62
VaR (95%, 1-day)-0.94%

As of Nov 18, 2026

Detailed Metrics

Additional measures remain available here while the decision pages stay focused.

Additional fundamental metrics

No additional fundamental metrics are available.

Additional technical indicators

No additional technical indicators are available.

Additional risk measures

No additional risk measures are available.

PEN Financial Data FAQ

What is Penumbra, Inc.'s revenue?

Penumbra, Inc.'s revenue is one of the core financial data points for PEN. Use it with revenue growth, margins, and EPS to understand whether sales are translating into earnings power.

Is Penumbra, Inc.'s revenue growing?

Revenue growth shows whether Penumbra, Inc. is expanding from prior periods. Compare growth with margins and free cash flow because faster sales growth is more valuable when profitability holds up.

What is PEN's EPS?

PEN's EPS, or earnings per share, helps connect net income to each share. EPS should be compared with EPS growth, P/E ratio, and analyst expectations.

What is Penumbra, Inc.'s net income?

Penumbra, Inc.'s net income shows profit after costs, taxes, and other expenses. It should be read with revenue, operating margin, EPS, and free cash flow.

How much free cash flow does Penumbra, Inc. generate?

Free cash flow shows how much cash Penumbra, Inc. generates after capital spending. It is useful for judging reinvestment capacity, buybacks, debt reduction, and valuation support.

How much cash and debt does Penumbra, Inc. have?

Cash and debt help frame PEN's balance-sheet flexibility. Compare liquidity and leverage with free cash flow and profitability before judging financial strength.